Company profile

John P. Groetelaars
Fiscal year end
Former names
Hillenbrand Industries Inc
IRS number

HRC stock data



31 Jul 20
3 Aug 20
30 Sep 20


Company financial data Financial data

Quarter (USD) Jun 20 Mar 20 Dec 19 Sep 19
Revenue 767.5M 723.2M 685M 782.8M
Net income 93.9M 46.9M 39.8M 27.9M
Diluted EPS 1.4 0.7 0.59 0.41
Net profit margin 12.23% 6.49% 5.81% 3.56%
Operating income 135.3M 87.3M 78.9M 94.1M
Net change in cash 41.3M 86.1M -9.7M 11.5M
Cash on hand 331.8M 290.5M 204.4M 214.1M
Cost of revenue 358.5M 355.7M 343.3M 397M
Annual (USD) Sep 19 Sep 18 Sep 17 Sep 16
Revenue 2.91B 2.85B 2.74B 2.66B
Net income 152.2M 252.4M 132.3M 122.8M
Diluted EPS 2.25 3.73 1.99 1.86
Net profit margin 5.24% 8.86% 4.82% 4.62%
Operating income 316.1M 289.4M 275M 230.3M
Net change in cash 31.1M -48.8M -400K 39.4M
Cash on hand 214.1M 183M 231.8M 232.2M
Cost of revenue 1.48B 1.45B 1.42B 1.4B

Financial data from Hill-Rom earnings reports

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
30 Jun 20 Ladone Mary Kay Common Stock Sell Dispose S Yes 110 2,278 250.58K 8,163
26 Jun 20 Ladone Mary Kay Common Stock Sell Dispose S Yes 106 3,125 331.25K 10,441
26 Jun 20 Ladone Mary Kay Common Stock Option exercise Aquire M No 53.7 3,125 167.81K 13,566
26 Jun 20 Ladone Mary Kay Employee Stock Option Common Stock Option exercise Dispose M No 53.7 3,125 167.81K 1,042
5 Jun 20 Johnson Paul Sherwood Common Stock Sell Dispose S Yes 104.909 2,258 236.88K 0
5 Jun 20 Johnson Paul Sherwood Common Stock Sell Dispose S Yes 104.419 2,741 286.21K 2,258
5 Jun 20 Johnson Paul Sherwood Common Stock Sell Dispose S Yes 103.296 5,345 552.12K 4,999
5 Jun 20 Rasin Deborah Common Stock Sell Dispose S Yes 102.81 3,795 390.16K 26,502
5 Jun 20 Rasin Deborah Common Stock Option exercise Aquire M No 47.29 3,795 179.47K 30,297
5 Jun 20 Rasin Deborah Common Stock Sell Dispose S Yes 102.81 3,222 331.25K 26,502
85.7% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 384 396 -3.0%
Opened positions 55 67 -17.9%
Closed positions 67 42 +59.5%
Increased positions 125 129 -3.1%
Reduced positions 137 136 +0.7%
13F shares
Current Prev Q Change
Total value 405.52B 336.36B +20.6%
Total shares 57.02M 56.64M +0.7%
Total puts 59.8K 255.5K -76.6%
Total calls 108K 50.3K +114.7%
Total put/call ratio 0.6 5.1 -89.1%
Largest owners
Shares Value Change
BLK BlackRock 7.03M $707.47M -4.0%
Vanguard 6.43M $647.22M +2.2%
Wellington Management 6.4M $644.07M -1.8%
Select Equity 3.87M $389.16B +37.6%
Victory Capital Management 1.74M $174.92M +983.0%
STT State Street 1.69M $170.21M +1.6%
FMR 1.28M $128.63M -30.8%
Cooke & Bieler 1.2M $121.14M +29.8%
AMP Ameriprise Financial 1.05M $105.37M +159.3%
BK Bank of New York Mellon 1.03M $103.63M -5.7%
Largest transactions
Shares Bought/sold Change
Victory Capital Management 1.74M +1.58M +983.0%
Select Equity 3.87M +1.06M +37.6%
Millennium Management 543.12K -751.31K -58.0%
Norges Bank 0 -693.64K EXIT
AMP Ameriprise Financial 1.05M +643.45K +159.3%
FMR 1.28M -570.12K -30.8%
Allianz Asset Management GmbH 324.35K -455.95K -58.4%
Renaissance Technologies 0 -378.62K EXIT
BLK BlackRock 7.03M -290.42K -4.0%
Cooke & Bieler 1.2M +276.2K +29.8%

Financial report summary

  • We face significant uncertainty in our industry due to government health care reform, medical device tax provisions in healthcare reform laws, changes in Medicare, Medicaid and other governmental medical program reimbursements, and we cannot predict how these reforms will impact our operating results.
  • We operate in a highly competitive industry that is subject to the risk of declining demand and pricing pressures, which could adversely affect our operating results.
  • We have a substantial amount of indebtedness. This level of indebtedness could adversely affect our ability to raise additional capital to fund operations, our flexibility in operating our business and our ability to react to changes in the economy or our industry.
  • Our variable rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase significantly.
  • Adverse developments in general domestic and worldwide economic conditions and instability and disruption of credit markets could have an adverse effect on our operating results, financial condition, or liquidity.
  • We might not be able to grow or achieve expected cost savings or profitability if we are unable to successfully acquire and integrate, or form business relationships with, other companies.
  • Failure to comply with regulations due to our contracts with U.S. government entities could adversely affect our business and results of operations.
  • The assets in our pension plans are subject to market disruptions. In addition, our pension plans are underfunded.
  • The majority of our products are manufactured at a single facility or location, and the material damage or loss of, or partial or complete labor-related work stoppage at, one or more of these facilities or locations could prevent us from manufacturing some of the various products we sell.
  • Our international sales and operations are subject to risks and uncertainties that vary by country and which could have a material adverse effect on our business and/or results of operations. Compliance with international laws and regulations, import and export limitations, trade agreements, anti-corruption laws, and exchange controls may be difficult, burdensome and expensive.
  • Unfavorable outcomes related to uncertain tax positions could result in significant tax liabilities.
  • We might not be able to attract, retain and develop key personnel.
  • We might not be successful in achieving expected operating efficiencies and sustaining or improving operating expense reductions, and might experience business disruptions and adverse tax consequences associated with restructuring, realignment and cost reduction activities.
  • We might be adversely affected by new regulations relating to conflict minerals.
  • The rationalization and transformation of our Enterprise Resource Planning (“ERP”) software solutions and other information technology systems could result in significant disruptions to our operations.
  • Our stock price and trading volume has been, and may continue to be, volatile from time to time and we may experience continued fluctuations in the future that could negatively impact the value of our outstanding shares.
Management Discussion
  • In this section, we provide an overview of our results of operations. We disclose segment information that is consistent with the way in which management operates and views the business. Our operating structure contains the following reportable segments:
  • See Note 1, Summary of Significant Accounting Policies and Note 2, Revenue Recognition, of our Consolidated Financial Statements in this Form 10-K for additional information on the impact of adoption of ASC 606 as of October 1, 2018.
  • Product sales and service revenue increased under ASC 606 by $112.2 million. This increase was primarily due to the accelerated recognition and reclassification from Rental revenue of $95.3 million for Front Line Care where it was determined for respiratory health products, there were no on-going performance obligations after delivery of the product to the customer, whereas previously this revenue was recognized over the period the Company was reimbursed by third parties. It also reflects an additional $13.5
Content analysis ?
H.S. freshman Avg
New words: buildup, Connecta, de, deployment, FICA, intensive, low, Mexico, modest, modification, multiplatform, physician, resume, Soft, video, Videomed, vital, volume
Removed: closure, compare, discussed, disruption, fourth, open, professional, rollforward, termination, TLA, unable


Wireless sensors in medical environments
28 Jul 20
Monitoring a patient can include a vital sign device including a skin contact and a demodulator circuit in communication with the electrically conductive skin contact, the demodulator circuit including: a physiological waveform data processing module configured to process the waveform data received from the electrically conductive skin contact; and a digitally encoded data processing module configured to detect and decode digitally encoded data modulated at the carrier frequency.
Person Support Apparatuses With Selectively Coupled Foot Sections
23 Jul 20
Person support apparatuses are disclosed.
Distributed Healthcare Communication System
23 Jul 20
A graphical audio station of a nurse call system is operable to permit a user to perform one or more of the following functions: establish a two-way voice communication link with another computer device in another patient and/or with a another computer device located in another staff work area and/or with a wireless communication device carried by caregiver and/or with a telephone of the healthcare facility; broadcast a voice page to a group of other selected computer devices; compose and send a text message to a portable device that is carried by a caregiver and that has wireless communication capability; browse web pages and/or view multimedia content, such as videos, hosted on servers of the healthcare facility and/or that are accessible via the Internet; view and/or acknowledge and/or answer and/or cancel alerts or nurse calls originating in a plurality of patient rooms.
RFID tag inlay for incontinence detection pad
21 Jul 20
An absorbent article has one or more fluid filter layers to inhibit electrode traces from being exposed to low volumes of fluid to reduce the number of false positives that are indicated by an RFID tag of the incontinence detection pad.
Foot end alert display for hospital bed
14 Jul 20
A patient support apparatus, such as a hospital bed, includes an alert light assembly or an alert light module having separate zones that are individually illuminated to convey information regarding respective alert conditions.